Medical Innovation Exchange

Pfizer pivots from early-stage rare disease R&D, shifting to external innovation and putting assets up for sale

https://www.fiercebiotech.com/biotech/pfizer-pivots-early-stage-rare-disease-rd-shifting-external-innovation-and-putting-assets

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!